All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation or HealthTree for Multiple Myeloma.

The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your Multiple Myeloma Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The Multiple Myeloma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Multiple Myeloma Hub cannot guarantee the accuracy of translated content. The Multiple Myeloma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.

Join the Multiple Myeloma Hub community

Stay up to date with the latest medical news in multiple myeloma by receiving trial data, therapy approvals, expert opinions, and more direct to your inbox. Sign up now!
Receive the latest updates in multiple myeloma
Areas of interest

About the newsletter

The Multiple Myeloma Hub newsletter provides healthcare professionals with up-to-date global advances in multiple myeloma relating to their classification, diagnosis, treatment, and management.

Each month our team research the latest unmet educational needs and produce evidence-based articles, videos, and podcasts that share new data, therapy approvals, expert opinions, and international congress coverage to enhance knowledge within the multiple myeloma community.